Mavik and pleural effusion Patient Reports February 11, 2012

Mavik Side Effects Report #4560150-6
Mavik side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Male patient, weighting 152.1 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: metastases to abdominal cavity, metastases to central nervous system, metastases to chest wall, non-small cell lung cancer, pleural effusion. Mavik dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.

Mavik Side Effects Report #4584526-6
Mavik side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Male patient, weighting 152.1 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: metastases to abdominal cavity, metastases to central nervous system, metastases to chest wall, non-small cell lung cancer, pleural effusion. Mavik dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.

Mavik Side Effects Report #4606273-4
Mavik side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Male patient, weighting 152.1 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: metastases to abdominal cavity, metastases to central nervous system, metastases to chest wall, non-small cell lung cancer, pleural effusion. Mavik dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.

Mavik Side Effects Report #4649724-1
Mavik side effect was reported by a Health Professional from on Apr 15, 2005. Male patient, 82 years of age, was treated with Mavik. After drug was administered, patient experienced the following side effects: pericardial effusion, pericarditis, pleural effusion, pleuropericarditis. Mavik dosage: unknown. During the same period patient was treated with SIMVASTATIN, ACETYLSALICYLATE, AMLODIPINE, BISOPROLOL FUMARATE, ISOSORBIDE MONITRATE. Patient was hospitalized. Patient recovered.